Rheum Dis Clin North Am. 2022 Aug;48(3):659-678. doi: 10.1016/j.rdc.2022.04.003.
ABSTRACT
The range of drug treatment options to treat acute and chronic gout has changed dramatically over the last 20 years. Yet, there is general consensus that drug therapy selection, dosing and dose titration, of both traditional and novel agents is far from optimally delivered in clinical practice. Updated guidelines disseminated in the last 5 years, from the American College of Physicians, the European League Against Rheumatism, and the American College of Rheumatology, provide clear guidance to the medical community on how and when to optimally integrate these therapeutic options into practice to improve the medical management of gout.
PMID:35953229 | DOI:10.1016/j.rdc.2022.04.003